Publikationen von H. Hermeking

Boon, R.; Iekushi, K.; Lechner, S.; Fischer, A.; Heydt, S.; Treguer, K.; Carmona, G.; Bonauer, A.; Horrevoets, A. J. G.; Girmatsion, Z. et al.; Biliczki, P.; Ehrlich, J. R.; Potente, M.; Zeiher, A. M.; Hermeking, H.; Dimmeler, S.: MicroRNA-34a is a pivotal age-induced regulator of cardiac apoptosis, telomere maintenance and contractile function: Implications for therapeutic inhibition. European Heart Journal 33 (Suppl. 1), S. 491 - 492 (2012)

Jung, P.; Menssen, A.; Mayr, D.; Hermeking, H.: AP4 encodes a c-MYC-inducible repressor of p21. Proceedings of the National Academy of Sciences of the United States of America 105 (39), S. 15046 - 15051 (2008)

Lodygin, D.; Tarasov, V.; Epanchintsev, A.; Berking, C.; Knyazeva, T.; Körner, H.; Knyazev, P.; Diebold, J.; Hermeking, H.: Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7 (16), S. 2591 - 2600 (2008)

Mathivanan, S.; Ahmed, M.; Ahn, N. G.; Alexandre, H.; Amanchy, R.; Andrews, P. C.; Bader, J. S.; Balgley, B. M.; Bantscheff, M.; Bennett, K. L. et al.; Bjorling, E.; Blagoev, B.; Bose, R.; Brahmachari, S. K.; Burlingame, A. S.; Bustelo, X. R.; Cagney, G.; Cantin, G. T.; Cardasis, H. L.; Celis, J. E.; Chaerkady, R.; Chu, F. X.; Cole, P. A.; Costello, C. E.; Cotter, R. J.; Crockett, D.; DeLany, J. P.; De Marzo, A. M.; DeSouza, L. V.; Deutsch, E. W.; Dransfield, E.; Drewes, G.; Droit, A.; Dunn, M. J.; Elenitoba-Johnson, K.; Ewing, R. M.; Van Eyk, J.; Faca, V.; Falkner, J.; Fang, X. M.; Fenselau, C.; Figeys, D.; Gagne, P.; Gelfi, C.; Gevaert, K.; Gimble, J. M.; Gnad, F.; Goel, R.; Gromov, P.; Hanash, S. M.; Hancock, W. S.; Harsha, H. C.; Hart, G.; Hays, F.; He, F. C.; Hebbar, P.; Helsens, K.; Hermeking, H.; Hide, W.; Hjerno, K.; Hochstrasser, D. F.; Hofmann, O.; Horn, D. M.; Hruban, R. H.; Ibarrola, N.; James, P.; Jensen, O. N.; Jensen, P. H.; Jung, P.; Kandasamy, K.; Kheterpal, I.; Kikuno, R. F.; Korf, U.; Körner, R.; Kuster, B.; Kwon, M. S.; Lee, H. J.; Lee, Y. J.; Lefevre, M.; Lehvaslaiho, M.; Lescuyer, P.; Levander, F.; Lim, M. S.; Lobke, C.; Loo, J. A.; Mann, M.; Martens, L.; Martinez-Heredia, J.; McComb, M.; McRedmond, J.; Mehrle, A.; Menon, R.; Miller, C. A.; Mischak, H.; Mohan, S. S.; Mohmood, R.; Molina, H.; Moran, M. F.; Morgan, J. D.; Moritz, R.: Human Proteinpedia enables sharing of human protein data. Nature Biotechnology 26 (2), S. 164 - 167 (2008)

Hermeking, H.: p53 enters the MicroRNA world. Cancer Cell 12 (5), S. 414 - 418 (2007)

Zhang, W.; Bauer, M.; Croner, R. S.; Pelz, J. O. W.; Lodygin, D.; Hermeking, H.; Sturzl, M.; Hohenberger, W.; Matzel, K. E.: DNA stool test for colorectal cancer: Hypermethylation of the secreted frizzled-related protein-1 gene. Diseases of the Colon & Rectum 50 (10), S. 1618 - 1626 (2007)

Jung, P.; Verdoodt, B.; Bailey, A.; Yates, J. R.; Menssen, A.; Hermeking, H.: Induction of Cullin 7 by DNA damage attenuates p53 function. Proceedings of the National Academy of Sciences of the United States of America 104 (27), S. 11388 - 11393 (2007)

Tarasov, V.; Jung, P.; Verdoodt, B.; Lodygin, D.; Epanchintsev, A.; Menssen, A.; Meister, G.; Hermeking, H.: Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing - miR-34a is a p53 target that induces apoptosis and G(1)-arrest. Cell Cycle 6 (13), S. 1586 - 1593 (2007)

Menssen, A.; Epanchintsev, A.; Lodygin, D.; Rezaei, N.; Jung, P.; Verdoodt, B.; Diebold, J.; Hermeking, H.: c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1. Cell Cycle 6 (3), S. 339 - 352 (2007)

Koch, H. B.; Zhang, R.; Verdoodt, B.; Bailey, A.; Zhang, C. D.; Yates, J. R.; Menssen, A.; Hermeking, H.: Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle 6 (2), S. 205 - 217 (2007)

Korner, H.; Epanchintsev, A.; Berking, C.; Schuler-Thurner, B.; Speicher, M. R.; Menssen, A.; Hermeking, H.: Digital karyotyping reveals frequent inactivation of the Dystrophin/DMD gene in malignant melanoma. Cell Cycle 6 (2), S. 189 - 198 (2007)

Verdoodt, B.; Benzinger, A.; Popowicz, G. M.; Holak, T. A.; Hermeking, H.: Characterization of 14-3-3sigma dimerization determinants. Cell Cycle 5 (24), S. 2920 - 2926 (2006)

Epanchintsev, A.; Jung, P.; Menssen, A.; Hermeking, H.: Inducible microRNA expression by an all-in-one episomal vector system. Nucleic Acids Research 34 (18), e119 (2006)

Hermeking, H.: 14-3-3 proteins and cancer biology. Seminars in Cancer Biology 16 (3), S. 161 - 161 (2006)

Hermeking, H.; Benzinger, A.: 14-3-3 proteins in cell cycle regulation. Seminars in Cancer Biology 16 (3), S. 183 - 192 (2006)

Lodygin, D.; Hermeking, H.: Epigenetic silencing of 14-3-3sigma in cancer. Seminars in Cancer Biology 16 (3), S. 214 - 224 (2006)

Benzinger, A.; Muster, N.; Koch, H. B.; Yates, J. R.; Hermeking, H.: Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Molecular & Cellular Proteomics 4 (6), S. 785 - 795 (2005)

Lodygin, D.; Epanchintsev, A.; Menssen, A.; Diebold, J.; Hermeking, H.: Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Research 65 (10), S. 4218 - 4227 (2005)

Benzinger, A.; Popowicz, G. M.; Joy, J. K.; Majumdar, S.; Holak, T. A.; Hermeking, H.: The crystal structure of the non-liganded 14-3-3 sigma protein: insights into determinants of isoform specific ligand binding and dimerization. Cell Research 15 (4), S. 219 - 227 (2005)

Lodygin, D.; Hermeking, H.: The role of epigenetic inactivation of 14-3-3 sigma in human cancer. Cell Research 15 (4), S. 237 - 246 (2005)